ARROWHEAD PHARMACEUTICALS, INC.

ARWR · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $10.5B · 711 employees
299
SEC Filings
$66.48
Close 2026-09-18
711
Employees

Business Summary

Arrowhead Pharmaceuticals develops RNAi-based medicines that silence disease-causing genes using its proprietary TRiM platform. The company has 18 drug candidates in clinical trials (Phase 1 through Phase 3) and achieved its first FDA-approved product, REDEMPLO (plozasiran), in 2025 for Familial Chylomicronemia Syndrome. Arrowhead has licensed multiple programs to partners including Amgen, Takeda, GSK, and Novartis, while retaining commercialization rights for key pipeline assets.

Latest Stock Quote

ARWR 2026-09-18 $66.48 O:$67.83 H:$68.05 L:$66.36 Vol:4.0M VWAP:$66.7088
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-07

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-11-252025-09-300000879407-25-000029EDGAR84K words
2024-11-262024-09-300001628280-24-049277EDGAR78K words
2023-11-292023-09-300001628280-23-040219EDGAR76K words
2022-11-282022-09-300001628280-22-030869EDGAR72K words
2021-11-222021-09-300001564590-21-057888EDGAR—
2020-11-232020-09-300001564590-20-054893EDGAR—
2019-11-252019-09-300001564590-19-044376EDGAR—
2018-12-112018-09-300001564590-18-030805EDGAR—
2017-12-122017-09-300001564590-17-024834EDGAR—
2016-12-142016-09-300001564590-16-030217EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-042026-06-300000879407-26-000057EDGAR28K words
2026-02-052025-12-310000879407-26-000034EDGAR90K words
2025-08-072025-06-300001628280-25-038858EDGAR22K words
2025-05-122025-03-310001628280-25-024666EDGAR21K words
2025-02-102024-12-310001628280-25-004634EDGAR64K words
2024-08-082024-06-300001628280-24-036104EDGAR18K words
2024-05-092024-03-310001628280-24-022215EDGAR17K words
2024-02-062023-12-310001628280-24-003492EDGAR15K words
2023-08-072023-06-300001628280-23-027771EDGAR24K words
2023-05-022023-03-310001628280-23-014856EDGAR22K words
2023-02-062022-12-310001628280-23-002413EDGAR18K words
2022-08-042022-06-300001628280-22-021068EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-040000879407-26-000058EDGAR2K words
2026-03-200000879407-26-000037EDGAR1K words
2026-02-050000879407-26-000033EDGAR2K words
2026-01-120001193125-26-010582EDGAR48K words
2026-01-090001193125-26-007971EDGAR2K words
2026-01-060000879407-26-000004EDGAR2K words
2025-11-250000879407-25-000027EDGAR2K words
2025-11-180000879407-25-000019EDGAR2K words
2025-09-120000879407-25-000010EDGAR49K words
2025-09-110000879407-25-000007EDGAR1K words

299 total filings indexed. 267 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

rare-genetic-diseases cardiovascular-and-metabolic-diseases severe-hypertriglyceridemia homozygous-familial-hypercholesterolemia metabolic-dysfunction-associated-steatohepatitis-(mash) obesity inflammatory-pulmonary-disease rna-interference-therapeutics rna-interference-(rnai) small-interfering-rna-(sirna) rna-induced-silencing-complex-(risc) targeted-rnai-molecule-(trim)-platform ligand-mediated-delivery sequence-specific-stabilization-chemistries

Company Identity

CIK0000879407
TickerARWR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.arrowheadpharma.com
Listed1995-02-01

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 12df5a3c24a847a41c2cd782741f9c67852c13bc89bece28177e84ac19632387
parent: e321b4814db7b20b78dab769e7335a30f02e5ad8ba571345fc651657eb0a18fe
content hash: f0801f124137df8c9ab277db856bf08e35b9e596bd90a44db301d4a36e04d427
signed: 2026-09-29T19:00:19.915Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ARWR using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ARWR, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ARWR (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.